Will long term oncologic follow-up make the case for robotic assisted radical cystectomy?

The use of robot-assisted radical cystectomy (RARC) has increased steadily over the last 15 years (1). The impetus for adopting minimally invasive surgery is based on decreased perioperative morbidity and length of stay compared to the gold standard, open radical cystectomy (ORC).